DeutschNewstral
Article
bizjournals.com on 2021-04-01 11:00
AngioDynamics pushes through pandemic with no layoffs and more research spending
Related news
- AngioDynamics slows spending as hospitals delay elective surgeries amid coronavirusbizjournals.com
- Federal tax repeal equals research boost, more stability for AngioDynamicsbizjournals.com
- AngioDynamics' backlog surpasses $4 million due to labor shortage, pandemicbizjournals.com
- AngioDynamics boosts R&D spending as it chases $3 billion marketbizjournals.com
Pandemic effect in Portsmouth: Layoffs, spending freezesSeacoastonline.com
AngioDynamics hails tax freezepoststar.com- AngioDynamics secures $100 million loanbizjournals.com
- Tech camp students tour AngioDynamicspoststar.com
- AngioDynamics acquires Israeli laser startupbizjournals.com
- AngioDynamics' CFO will leave companybizjournals.com
- AngioDynamics licenses microsphere treatment technologybizjournals.com
- AngioDynamics expands oncology business with RadiaDyne acquisitionbizjournals.com
- AngioDynamics sells manufacturing plant for $5.75 millionbizjournals.com
- AngioDynamics projects solid sales growth in 2016bizjournals.com
- AngioDynamics' bold move: get smaller (for now)bizjournals.com
- AngioDynamics eliminates top oncology job, overhauls unitbizjournals.com
- TPandemic Spendingthenav.ca
- AngioDynamics expands oncology business with acquisition of Houston co.bizjournals.com
- Oncology business propels AngioDynamics to $91.5 million second quarterbizjournals.com
- AngioDynamics will pay $12.5 million to resolve false claims casebizjournals.com